Cell Culture Market to be Worth $60.27 Billion by 2030: Grand View Research, Inc.

SAN FRANCISCO, Aug. 25, 2022 /PRNewswire/ -- The global cell culture market size is expected to reach USD 60.27 billion by 2030, expanding at a CAGR of 11.9% from 2022 to 2030, according to a new report by Grand View Research, Inc. This can be attributed to the increase in biopharmaceutical production, advancements in vaccine research and development, and increasing focus on genetic engineering applications that rely heavily on cell culture techniques.

Key Industry Insights & Findings from the report:

• By consumable, the media segment accounted for the largest revenue share of over 50.0% in 2021 due to the availability of a variety of serum- and animal component-free and customized media alternatives, which has increased the market penetration for media products.
• Based on product, culture systems held the largest revenue share of over 25.0% in 2021. This can be attributed to the technological advancements in automated systems for research & development applications.
• The biopharmaceuticals application segment dominated the market in 2021 with a revenue share of over 25.0% due to the involvement of mammalian lines, such as the Chinese hamster ovary, in the manufacturing of biopharmaceuticals and the rising demand for non-conventional drugs.
• North America held the largest revenue share in 2021 due to high research and development investments, the presence of a well-established scientific infrastructure, significant demand for animal component-free media, and other factors.
• The Asia Pacific region is estimated to grow at the fastest rate over the forecast period due to the growing healthcare expenditure, rising awareness regarding regenerative therapies, and a large potential for clinical research applications.

Read 120-page full market research report for more Insights, "Cell Culture Market Size, Share & Trends Analysis Report By Consumable (Media, Sera, Reagents), By Product (Culture Systems, Centrifuges), By Application, By Region, And Segment Forecasts, 2022 - 2030", published by Grand View Research.

Cell Culture Market Growth & Trends

Innovations in cell culture workflow automation, such as the commercial development of integrated robotic liquid handling systems, are expected to significantly boost the capabilities of current cell culture technologies. For instance, culturing processes are expected to witness improvements in capacity handling and efficiency, and reproducibility in operations. Similarly, automation in cell line development technologies is gaining traction with the launch of new platforms. For instance, in October 2021, CYTENA launched C.STATION, a fully automated cell line development platform, for enhancing antibody and gene therapy production. Such product launches are likely to increase the market penetration of cell culture offerings.

Cell culture models play a pivotal role in the development of novel therapeutics for diseases such as diabetes, cancer, and Parkinson's diseases. With the increasing emphasis on research and development activities exploring therapeutic candidates for such diseases, the demand for customized media for use in preclinical research is expected to drive the market. Furthermore, demand for serum-free media is likely to witness significant growth due to increasing quality constraints in biopharmaceuticals and the requirement for highly consistent and standardized culturing conditions.

The COVID-19 pandemic has boosted the demand for cell culture products due to the significant role played by culturing technologies in the discovery of novel diagnostic and therapeutic options for the disease. For instance, research applications such as high-throughput COVID-19 drug screening for the identification of potential drug candidates or investigations aimed at understanding the mechanism of viral entry into the host cells are expected to positively affect the market growth. Furthermore, culturing techniques offer essential tools for the production of viral particles for vaccine development, thereby broadening the growth prospects in this domain.

Cell Culture Market Segmentation

Grand View Research has segmented the global cell culture market based on consumable, product, application, and region 

Cell Culture Market - Consumable Outlook (Revenue, USD Million, 2018 - 2030)

• Media
• Minimum Essential Media (MEM)
• RPMI 1640 Media
• DMEM/F-12 Media
• F-10 Serum Free Media
• BME Media
• Insect Media
• Other Media
• Sera
• Fetal Bovine Serum
• Other AnimalSerum
• Reagents
• Albumin
• Other

Cell Culture Market - Product Outlook (Revenue, USD Million, 2018 - 2030)

• Culture Systems
• Incubators
• Centrifuges
• Cryostorage Equipment
• Biosafety Equipment
• Pipetting Instruments

Cell Culture Market - Application Outlook (Revenue, USD Million, 2018 - 2030)

• Biopharmaceuticals
• Tissue Culture & Engineering
• Vaccine Production
• Drug Development
• Gene Therapy
• Toxicity Testing
• Cancer Research
• Others

Cell Culture Market - Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Italy
• Spain
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Latin America
• Brazil
• Mexico
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• UAE

List of Key Players of the Cell Culture Market

• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Becton, Dickinson and Company
• Merck KGaA
• Sartorius AG
• VWR International, LLC
• Eppendorf SE
• PromoCell GmbH
• Bio-Techne Corporation
• BioSpherix, Ltd.

Check out more related studies published by Grand View Research:

• Cell Culture Media Market - The global cell culture media market size is expected to reach USD 10.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.1% from 2022 to 2030. Expansion of biosimilars and biologics, growth in stem cell research, and emerging bio manufacturing technologies for cell-based vaccines are the major factors which are likely to drive the market. For instance, in October 2021, the Australian Government funded the Australian-led stem cell research through USD 25 million in grants.
• Primary Cell Culture Market - The global primary cell culture market size is expected to reach USD 8.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.6% from 2021 to 2028. The market growth is owing to several factors such as advancement in genetic engineering, rising demand for regenerative medicines, and robust funding for cellular therapies development.
• In-vitro Toxicology Testing Market - The global in-vitro toxicology testing market size is expected to reach USD 51.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.7% from 2021 to 2028. In recent times, the validation and acceptance of in-vitro and alternative testing methods by regulatory agencies are increasing at lucrative pace. Also, ongoing technological advancements to replace the use of animals for toxicology testing purposes have spurred the use of in vitro testing models, in turn, driving the market.

Browse through Grand View Research's Biotechnology Industry Research Reports.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Grand View Compass | Astra ESG Solutions
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg